FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Leuprolide acetate 11.25 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Leuprolide acetate 11.25 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Leuprolide acetate 3.75 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Leuprolide acetate 3.75 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
topotecan 4mg powder for infusion solution vial (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
topotecan 4mg powder for infusion solution vial (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
vancomycine 500 mg, fiole de poudre pour perfusion (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
vancomycine 500 mg, fiole de poudre pour perfusion (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Palivizumab 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Palivizumab 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Treosulfan 5 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Treosulfan 5 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
floxacilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
floxacilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Vinblastine sulfate 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Vinblastine sulfate 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely valproate sodium 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely valproate sodium 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
floxacilline 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
floxacilline 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
floxacilline 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Prednisolone 3 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
iséthionate de pentamidine 300 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
iséthionate de pentamidine 300 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Naproxen 25 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Product containing precisely tramadol hydrochloride 50 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely tramadol hydrochloride 50 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Isoniazid 10 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely nitrazepam 1 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Porfimer sodium 15 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Porfimer sodium 15 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Paclitaxel 100 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Paclitaxel 100 mg powder for suspension for injection vial Count of base of active ingredient False un Inferred relationship Some
somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
gemcitabine 200mg powder for infusion solution vial (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
gemcitabine 200mg powder for infusion solution vial (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Treosulfan 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Treosulfan 1 g powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Treosulfan 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion Has presentation strength denominator value False un Inferred relationship Some 1
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1

Start Previous Page 184 of 217 Next End

This concept is not in any reference sets

Back to Start